Scioto Biosciences has announced positive topline results from their phase 1b trial evaluating the novel probiotic SB-121 (Lactobacillus reuteri with dextran microparticles and maltose) in individuals […]
COPENHAGEN, Denmark — Use of the dual interleukin-17 (IL-17) inhibitor bimekizumab (Bimzelx) was associated with rapid reductions in signs and symptoms of radiographic axial spondyloarthritis, reported […]
The Division of Hematologic Malignancies 1 (DHM1) manages Investigational New Drug Applications (INDs), New Drug Applications (NDAs), and Biologic Licensing Applications (BLAs) for: Acute leukemias and […]
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.